Post by
Directvoice on Mar 14, 2024 1:25pm
In the good direction
In good direction to be the worst stock for investors I think this stock needs to pivot to a different business direction in the oncology sector . With RNA cancer vacine that will soon be available, maybe they will find a new uses for Aristole